The FDA approves Pfizer's RSV vaccine, Abrysvo, for adults aged 18-59 years with increased risk of the disease.

A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.

COVID-19 vaccination is associated with a reduced risk for most CV events, but with slightly increased risks for extrasystoles and transient ischemic attack, as well as myocarditis and pericarditis ...

COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews ...

The vaccine could provide immunity against the illness, which causes vomiting and diarrhoea and causes 200,000 deaths ...

Living a healthy lifestyle takes effort, but it’s also straightforward. Be committed. Exercise. Eat right. Avoid fads and ...

A world-first vaccine for the vomiting bug norovirus is being trialled in the UK, with the hope it could cut the "burden" on ...